EPAS1 and breast cancer: Similarly, HIF-2α exhibits a higher positive rate TNBC subtype breast cancer (26 positive in 32 total cases; 81.2%) than luminal subtype breast cancer (20 positive in 36 total cases; 55.6%; χ2 = 5.110; p = 0.024).